Viking Therapeutics Skyrockets On Obesity Drug Data. Lilly Rises, But Novo Falls.
Viking stock catapulted Tuesday on "stellar" test results for its weight-loss shot, sending Novo down.
- Why Viking Stock Jumped On Obesity Data. Novo Falls. · investors.com · about 19 hours ago
- Novo and Lilly Challenged: Viking Stock Surges on Weight-Loss Drug Trial · barrons.com · about 19 hours ago
- Viking Thera stock jumps on obesity drug data (VKTX:NASDAQ) · seekingalpha.com · about 24 hours ago
- Viking Therapeutics Stock Surges 30% After Weight-Loss Drug Trial · barrons.com · 1 day ago
- Viking Therapeutics Stock Surges 26% After Weight-Loss Drug Trial · barrons.com · 1 day ago
- Viking Therapeutics Stock Surges 36% After Weight-Loss Drug Trial · barrons.com · 1 day ago
- Viking Therapeutics stock soars on obesity data (VKTX:NASDAQ) · seekingalpha.com · 1 day ago
- Viking Therapeutics Spikes On Obesity Drug Data. Eli Lilly, Novo Fall. · investors.com · 1 day ago
- Viking Therapeutics Skyrockets On Obesity Drug Data. Eli Lilly, Novo Fall. · investors.com · 1 day ago
- Viking Therapeutics stock surges 27% on weight loss drug data · investing.com · 1 day ago